Nature Communications (Jun 2021)
Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen
Abstract
Stool biomarkers hold promise for monitoring disease activity and predicting clinical course in inflammatory bowel disease (IBD) as they originate from the inflamed tissue. Here the authors report an aptamer-based proteomic screen, and discover several stool proteins that predict remission at four weeks.